Skip to main content
. 2011 Dec 5;9(3):245–254. doi: 10.1038/cmi.2011.50

Figure 7.

Figure 7

The responses of the PBMCs and SFMCs from RA patients to viral peptides and autoantigen peptides. Compared to the PBMCs from healthy donors, EBVgp110 and HLA-DR4 induced a more significant proliferation of PBMCs and SFMCs from RA patients. SFMCs had the strongest reactive efficacy (all experiments were repeated three times). cpm, counts per million; EBV, Epstein–Barr virus; PBMC, peripheral blood mononuclear cell; RA, rheumatoid arthritis; SFMC, synovial fluid mononuclear cell; TT, tetanus toxin; TTp, tetanus toxoid peptide.